UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
22.70
-0.72 (-3.07%)
At close: Jan 2, 2026, 4:00 PM EST
22.71
+0.01 (0.04%)
After-hours: Jan 2, 2026, 4:10 PM EST
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.06 billion as of January 2, 2026. Its market cap has increased by 121.83% in one year.
Market Cap
1.06B
Enterprise Value
1.07B
1-Year Change
121.83%
Ranking
Category
Stock Price
$22.70
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.06B, an increase of 484.15%. That is a compound annual growth rate of 22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |